Shares of Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) fell 0.4% during trading on Monday . The company traded as low as $20.40 and last traded at $20.40. 750 shares traded hands during trading, an increase of 321% from the average session volume of 178 shares. The stock had previously closed at $20.48.
Hikma Pharmaceuticals Stock Performance
The stock’s 50-day moving average is $22.16 and its 200-day moving average is $24.43. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- 3 Tickers Leading a Meme Stock Revival
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Dell and HP Are Raising Prices—And Investors Should Take Note
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
